UT MD Anderson researchers led by Tina Cascone, M.D., Ph.D., found that ctDNA clearance and MRD status may help identify which patients with resectable non-small cell lung cancer get the greatest benefit from immunotherapy given before and after surgery.

The University of Texas MD Anderson Cancer Center is one of the world’s most respected centers devoted exclusively to cancer patient care, research, education and prevention. Its sole mission is to end cancer for patients and their families around the world. UT MD Anderson provides cancer care in Houston’s Texas Medical Center, as well as several locations throughout the Greater Houston Area. UT MD Anderson also collaborates with hospitals, health systems and organizations across the U.S. and around the world to advance our mission to end cancer. UT MD Anderson was created in 1941 as part of The University of Texas System, and, in 1971, it became one of the nation’s original three comprehensive cancer centers designated by the National Cancer Act of 1971. U.S. News & World Report’s “Best Hospitals” rankings has named UT MD Anderson the nation's top hospital for cancer care. The institution has been named one of the nation’s top two hospitals for cancer care every year since the survey began in 1990. The recognition reflects the passion of our 27,000 extraordinary employees and 1,000 volunteers for providing exceptional care to our patients and their families, and for realizing our mission to #EndCancer. You can view all of our career opportunities at Careers.MDAnderson.Org.